Clinical Trial Update: Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI) [NA]

View source ↗

Summary

Clinical trial update on short-term, high-dose atorvastatin given around percutaneous coronary intervention to assess effects on periprocedural myonecrosis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2015-09-22